Skip to main content
. 2014 Dec 11;8(1):33–41. doi: 10.1007/s12307-014-0161-7

Fig. 1.

Fig. 1

Study design including the main inclusion and exclusion criteria. ECOG Eastern cooperative oncology group performance status, CRPC Castration-resistant prostate cancer, PSA Prostate-specific antigen, AE Adverse event, SAE Serious adverse event